At a glance
ClinicalIndex Comparison RecordPhase 4Completed· 28 enrolled
Drug / intervention
Adapalene/benzoyl peroxide gel, 0.1%/2.5% +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Epiduo® (Adapalene and Benzoyl Peroxide) Gel 0.1%/2.5% Pump, Cetaphil® DermaControl™ Moisturizer SPF 30, and Cetaphil® DermaControl™ Foam Wash Regimen in Student Athletes With Mild to Moderate Acne Vulgaris
In Brief
A Phase 4 clinical trial evaluating Adapalene/benzoyl peroxide gel, 0.1%/2.5% and Cetaphil Acne Regimen for Acne Vulgaris. Completed, enrolled 28 participants across 1 site.
Detailed Summary
The goal of this study is to evaluate a complete topical acne regimen consisting of a prescription acne medication (Epiduo® Gel) and an acne-specific cleanser (Cetaphil® DermaControl™ Foam Wash) and moisturizer with sunscreen (Cetaphil® DermaControl™ Moisturizer SPF 30) for safety, efficacy and patient satisfaction in student athletes with acne vulgaris.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsAcne Vulgaris
CountriesUnited States
Collaborators--
Timeline
Phase 4CompletedFinished
201520162017201820192020202120222023202420252026
Enrollment StartAug 2014
First PostedSep 2014
Primary CompletionFeb 2015
TodayJul 2026
First PostedSep 25, 2014
Enrollment StartAug 1, 2014
Primary CompletionFeb 1, 2015
TodayJul 2, 2026
Enrollment to primary: 6 monthsPosted 11.8 years ago
Interventions
Adapalene/benzoyl peroxide gel, 0.1%/2.5%drug
Topical AV therapy
Cetaphil Acne Regimenother
Cleanse, Moisturize, and Protect